HEALTH CHAIN GROUP (HCG) acquired by ANJAC BEAUTY & HEALTH
Context
Anjac acquired a majority stake in HCG to accelerate its growth in the nutraceutical space. This is the 17th company to join the Anjac ecosystem. Beyond the acquisition cost, Anjac has committed to a EUR25M investment plan to expand the Velenje production site, aiming to triple its output within 12 months. The historical founders remain as operational partners.
By taking control of Health Chain Group, Anjac Beauty & Health continues its expansion strategy. Previously, the group had completed 2 acquisitions, including Stephid in 2023.
HEALTH CHAIN GROUP (HCG), which reported an EBITDA margin of in 2025, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Health Chain Group is a Slovenian specialist in the development and manufacturing of high-end food supplements. The group operates via three key subsidiaries: PharmaLinea (B2B branded ingredients), Hermes Consilium (distribution), and ErgoPharma (manufacturing). HCG is recognized for its scientifically backed formulations and modern Corporate facility located in Velenje, Slovenia.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 12/2025 | MONTAGU PRIVATE EQUITY / Kohlberg | Teleflex Medical OEM | UNITED STATES | Medical Consumables |
| 12/2025 | CHARTERHOUSE | WINBACK | FRANCE | Medical Devices |
| 11/2025 | PFIZER | METSERA | UNITED STATES | R&D Biotech |
| 11/2025 | ARLANE | DESSINTEY | FRANCE | Medical Devices |
| 10/2025 | PUBLIC MARKETS (IPO) | OTTOBOCK | GERMANY | Implants & Prosthetics |
| 09/2025 | INVESTCorporate | DCC HEALTHCARE | UNITED KINGDOM | CDMO |
| 09/2025 | CAPVEST PARTNERS | STADA | GERMANY | Generics / Labs |
| 09/2025 | HEARTLAND FOOD PRODUCTS | SLIMFAST | UNITED STATES | Nutrition & Dietary Supplements |
| 09/2025 | CREDIT MUTUEL EQUITY / EURAZEO / BPIFRANCE / BNP PARIBAS DEVELOPPEMENT | PROTEOR | FRANCE | Implants & Prosthetics |
| 08/2025 | TERUMO | ORGANOX | UNITED KINGDOM | Medical Devices |
REFERENCES
Revenue range: 25M - 50M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of HEALTH CHAIN GROUP (HCG) by ANJAC BEAUTY & HEALTH are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: health chain group (hcg)